Small intestinal alterations in severely obese hyperglycemic subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 2, 2011, Pages

  Verdam, Froukje J ^a   Greve, Jan Willem M ^a,b   Roosta, Sedigheh ^a   Van Eijk, Hans ^a   Bouvy, Nicole ^a   Buurman, Wim A ^a   Rensen, Sander S ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CITRULLINE; FATTY ACID BINDING PROTEIN 2; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CELL LOSS; CELL PROLIFERATION; CELL VOLUME; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INTESTINE CELL; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL;

ADULT; BIOPSY; CELL PROLIFERATION; CHRONIC DISEASE; CITRULLINE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENTEROCYTES; FATTY ACID-BINDING PROTEINS; FEMALE; GLUCAGON-LIKE PEPTIDE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; INTESTINE, SMALL; MALE; OBESITY; ORGAN SIZE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RODENTIA;

EID: 79951687964     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1333     Document Type: Article

References (18)

1. Shaw JE, Sicree RA, Zimmet PZ 2010 Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4-14
2. Drucker DJ 2007 The role of gut hormones in glucose homeostasis. J Clin Invest 117:24-32 (Pubitemid 46048446)
3. Troy S, Soty M, Ribeiro L, Laval L, Migrenne S, Fioramonti X, Pillot B, Fauveau V, Aubert R, Viollet B, Foretz M, Leclerc J, Duchampt A, Zitoun C, Thorens B, Magnan C, Mithieux G, Andreelli F 2008 Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 8:201-211
4. Rubino F, R'bibo SL, del Genio F, Mazumdar M, McGraw TE 2008 Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol 6:102-109
5. Adachi T, Mori C, Sakurai K, Shihara N, Tsuda K, Yasuda K 2003 Morphological changes and increased sucrase and isomaltase activity in small intestines of insulin-deficient and type 2 diabetic rats. Endocr J 50:271-279 (Pubitemid 36830003)
6. Crenn P, Messing B, Cynober L 2008 Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 27: 328-339
7. Drozdowski L, Thomson AB 2009 Intestinal hormones and growth factors: effects on the small intestine. World J Gastroenterol 15: 385-406
8. Pelsers MM, Hermens WT, Glatz JF 2005 Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 352:15-35 (Pubitemid 40093855)
9. van Eijk HM, van der Heijden MA, van Berlo CL, Soeters PB 1988 Fully automated liquid-chromatographic determination of amino acids. Clin Chem 34:2510-2513 (Pubitemid 19017261)
10. Gillett MJ 2009 International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes: Diabetes Care 2009; 32(7):1327-1334. Clin Biochem Rev 30:197-200
11. Lieberman JM, Sacchettini J, Marks C, Marks WH 1997 Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery 121:335-342 (Pubitemid 27114453)
12. Noda T, Iwakiri R, Fujimoto K, Yoshida T, Utsumi H, Sakata H, Hisatomi A, Aw TY 2001 Suppression of apoptosis is responsible for increased thickness of intestinal mucosa in streptozotocin-induced diabetic rats. Metabolism 50:259-264 (Pubitemid 32248969)
13. Dyer J, Wood IS, Palejwala A, Ellis A, Shirazi-Beechey SP 2002 Expression of monosaccharide transporters in intestine of diabetic humans. Am J Physiol Gastrointest Liver Physiol 282:G241-G248 (Pubitemid 34651680)
14. Mithieux G, Bady I, Gautier A, Croset M, Rajas F, Zitoun C 2004 Induction of control genes in intestinal gluconeogenesis is sequential during fasting and maximal in diabetes. Am J Physiol Endocrinol Metab 286:E370-E375 (Pubitemid 38292686)
15. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palù G, Martines D 2007 Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292:G518-G525
16. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck AM, Lambert DM, Muccioli GG, Delzenne NM 2009 Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58:1091-1103
17. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S 2007 Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740-E747 (Pubitemid 46411051)
18. Stephens AN, Pereira-Fantini PM, Wilson G, Taylor RG, Rainczuk A, Meehan KL, Sourial M, Fuller PJ, Stanton PG, Robertson DM, Bines JE 2010 Proteomic analysis of the intestinal adaptation response reveals altered expression of fatty acid binding proteins following massive small bowel resection. J Proteome Res 9:1437-1449